Wen Pan

925 total citations
38 papers, 627 citations indexed

About

Wen Pan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Wen Pan has authored 38 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Immunology and 11 papers in Oncology. Recurrent topics in Wen Pan's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Nanoplatforms for cancer theranostics (5 papers). Wen Pan is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Nanoplatforms for cancer theranostics (5 papers). Wen Pan collaborates with scholars based in China, United States and Germany. Wen Pan's co-authors include Shouzhuo Yao, Yan Huang, Yingju Liu, Manli Guo, Bin Feng, Ji Wang, Xiaojuan Wang, Yuanzeng Min, Zhi‐Liang Ji and Quan Xu and has published in prestigious journals such as Nucleic Acids Research, Nature Immunology and Biomaterials.

In The Last Decade

Wen Pan

36 papers receiving 619 citations

Peers

Wen Pan

IMMUN

EPIDE

EEE

Guixin Li China

Yeping Yu China

Jianyi Wang China

Jinling Zhang China

Chunli Li China

Veli‐Pekka Ranta Finland

Qiao Zhang China

Massimo Breda Italy

Wai‐Keung Chui Singapore

Guixin Li China

Wen Pan

352 ×1.7

123 ×0.8

44 ×0.4

IMMUN

215 ×2.7

EPIDE

72 ×1.1

EEE

Citations per year, relative to Wen Pan Wen Pan (= 1×) peers Guixin Li

Countries citing papers authored by Wen Pan

Since Specialization

Citations

This map shows the geographic impact of Wen Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Pan more than expected).

Fields of papers citing papers by Wen Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Pan. The network helps show where Wen Pan may publish in the future.

Co-authorship network of co-authors of Wen Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Pan. A scholar is included among the top collaborators of Wen Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Pan. Wen Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Wen, et al.. (2025). Cystobacter fuscus HM-E: a novel biocontrol agent against cotton Verticillium wilt. Frontiers in Microbiology. 16. 1555523–1555523. 1 indexed citations

Pan, Wen, et al.. (2024). Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance. Advanced Functional Materials. 34(45). 4 indexed citations

Pan, Wen, et al.. (2024). The predictive value of serum IL‐17A and IL‐6 expression in postoperative recurrence in patients with intrauterine adhesion. American Journal of Reproductive Immunology. 91(1). e13808–e13808.

Bie, Nana, Wen Pan, Ya‐Ru Miao, et al.. (2024). A method for predicting drugs that can boost the efficacy of immune checkpoint blockade. Nature Immunology. 25(4). 659–670. 12 indexed citations

Pan, Wen, Chao Liu, Tao Ren, et al.. (2024). Exploration of lncRNA/circRNA-miRNA-mRNA network in patients with chronic atrophic gastritis in Tibetan plateau areas based on DNBSEQ-G99 RNA sequencing. Scientific Reports. 14(1). 9212–9212. 3 indexed citations

Pan, Wen, et al.. (2024). A carrier-free nanovaccine combined with cancer immunotherapy overcomes gemcitabine resistance. Biomaterials. 313. 122788–122788. 7 indexed citations

Pan, Wen, et al.. (2022). Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy. Acta Biomaterialia. 158. 698–707. 12 indexed citations

Pan, Wen, Chuang LIU, Yunhui Li, et al.. (2021). Ultrathin tellurium nanosheets for simultaneous cancer thermo-chemotherapy. Bioactive Materials. 13. 96–104. 34 indexed citations

Chang, Xiaoyan, et al.. (2021). The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19. International Immunopharmacology. 97. 107569–107569. 13 indexed citations

10.

Xiong, Shue, Dan Zhu, Boyun Liang, et al.. (2021). Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss. EBioMedicine. 69. 103464–103464. 17 indexed citations

11.

Pan, Wen, Andreas Walker, Daniel Hoffmann, et al.. (2018). Differential escape of HCV from CD8⁺ T cell selection pressure between China and Germany depends on the presenting HLA class I molecule. Journal of Viral Hepatitis. 26(1). 73–82. 2 indexed citations

12.

Wang, Qin, Wen Pan, Yanan Liu, et al.. (2018). Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment. Frontiers in Immunology. 9. 219–219. 40 indexed citations

13.

Liu, Ming, Dawei Pan, Wen Pan, et al.. (2017). In-situ synthesis of reduced graphene oxide/gold nanoparticles modified electrode for speciation analysis of copper in seawater. Talanta. 174. 500–506. 26 indexed citations

14.

Pan, Wen, et al.. (2015). Genetic Diversity Analysis for Leaf Main Traits of Camellia azalea. Zhiwu yanjiu. 35(5). 730. 1 indexed citations

15.

Cai, Mei‐Chun, et al.. (2014). ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms. Nucleic Acids Research. 43(D1). D907–D913. 72 indexed citations

16.

Pan, Wen, et al.. (2013). Peripheral blood CD40–CD40L expression in human breast cancer. Irish Journal of Medical Science (1971 -). 182(4). 719–721. 9 indexed citations

17.

Pan, Jianbo, et al.. (2013). High-throughput identification of off-targets for the mechanistic study of severe adverse drug reactions induced by analgesics. Toxicology and Applied Pharmacology. 274(1). 24–34. 12 indexed citations

18.

Pan, Wen. (2012). Decontamination ability of sulfur dioxide and nitrogen dioxide for 38 young landscaping plants in Guangzhou city. Soil and Environmental Sciences. 3 indexed citations

19.

Zhang, Fangqiu, et al.. (2010). Studies on morphological structure and flower stage of Rhodoleia plants in Guangdong.. Journal of the South China Agricultural University. 31(3). 16–18. 2 indexed citations

20.

Huang, Yan, Wen Pan, Manli Guo, & Shouzhuo Yao. (2007). Capillary electrophoresis with end-column electrochemiluminescence for the analysis of chloroquine phosphate and the study on its interaction with human serum albumin. Journal of Chromatography A. 1154(1-2). 373–378. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact